- In December 2023, Danaher Corporation (U.S.) completed the acquisition of Abcam (U.K.), a company specializing in providing validated antibodies, reagents, biomarkers, and assays critical for drug discovery, life sciences research, and diagnostics, strengthening Danaher’s footprint in scientific research solutions and boosting its diagnostic capabilities
- In May 2023, bioMérieux SA (France) secured a U.S. Food and Drug Administration (FDA) Clinical Laboratory Improvement Amendments (CLIA) waiver for its fast and accurate multiplex PCR-based BIOFIRE SPOTFIRE Respiratory (R) Panel Mini, enhancing the company’s position in the respiratory diagnostics market and reinforcing its commitment to accessible testing
- In November 2022, IDEXX expanded its water microbiology testing portfolio by acquiring Tecta-PDS, a Canadian company known for its automation-driven water testing technology, allowing IDEXX to strengthen its laboratory and on-site testing solutions and support broader market reach
- In November 2022, Archer Daniels Midland (ADM) inaugurated a new microbiology laboratory at its ADM Specialty Manufacturing facility in Decatur, Illinois, effectively doubling the laboratory space and advancing the site's testing capabilities, positioning ADM for greater innovation and efficiency in microbiology operations
Frequently Asked Questions
The key trends in the microbiology testing market is the integration of artificial intelligence (ai) in microbiology testing.
The major factors driving the growth of the microbiology testing market is the growing demand for rapid diagnostics and point-of-care testing.
The primary challenges in the microbiology testing market include challenges with standardization and regulatory approval.
